FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387362461> ?p ?o ?g. }

• W4387362461 abstract "Abstract Disclosure: Z. Tan: None. E. Briggie: None. M. Correia: None. Background: Moyamoya disease is an uncommon cerebrovascular disease that is featured by narrowing of large intracranial arteries and the development of prominent small-vessel collaterals. The etiology of Moyamoya disease is unknown, but it can be associated with multiple conditions including atherosclerosis, sickle cell disease, and Protein S deficiency. It is rarely associated with uncontrolled Graves’ disease. Clinical Case: A 37-year-old female with a history of Graves’ disease and type 1 diabetes presented with sudden onset of slurred speech and right-sided weakness. A CTA of the head and neck showed a small hypodensity in the left basal ganglia without corresponding perfusion deficit and narrowed left internal carotid arteries without focal stenosis. In addition, a brain MRI showed patchy infarcts in the left middle cerebral artery territory. A cervical and cerebral angiogram showed multiple areas of stenosis which was concerning for Moyamoya disease. She ultimately underwent balloon angioplasty of the left internal carotid artery with improvement in perfusion. During the workup for secondary causes of Moyamoya disease, her TSH was &lt; 0.01 µIU/mL (0.270-4.20 µIU/mL), with elevated T4 at 3.84 ng/dl (0.80-1.80 ng/dl) and elevated TSI at 15.5 IU/L (&lt; 0.54 IU/L). Importantly, she was diagnosed with Graves’ disease 2 years before admission, and this condition has never been well controlled due to poor compliance with methimazole. A TSH measured 5 months before admission was also undetectable with elevated T4 at 2.8 ng/dl. Her other workups for Moyamoya disease were negative including HIV antigen/antibody, syphilis IgG antibody, Lyme disease IgG & IgM antibodies, hepatitis panel antibodies, ANA, ANCA, free protein S, dsDNA antibody, factor 5 Leiden mutation, vascular endothelial growth factor-D and urine drug screening test. She started methimazole 20 mg daily and was discharged to acute rehabilitation. After rehabilitation, her Graves’ disease is slowly improving with most recent TSH &lt; 0.008 µIU/mL and free T4 at 2.39 ng/dl. She is almost back to her baseline with significant improvement in speech and strength. Conclusion: Uncontrolled Graves’ disease should be considered in the differential diagnosis of Moyamoya disease in young subjects who present with stroke-like symptoms. Reference: Ischemic Stroke and Intraventricular Hemorrhage in Moyamoya Syndrome Associated With Graves' Disease: A Case Report. Neurologist 2022 Presentation Date: Saturday, June 17, 2023" @default.
• W4387362461 created "2023-10-06" @default.
• W4387362461 creator A5037510195 @default.
• W4387362461 creator A5074328280 @default.
• W4387362461 creator A5093007384 @default.
• W4387362461 date "2023-10-01" @default.
• W4387362461 modified "2023-10-06" @default.
• W4387362461 title "SAT474 A Case Report Of Moyamoya Disease Associated With Uncontrolled Graves' Disease" @default.
• W4387362461 doi "https://doi.org/10.1210/jendso/bvad114.1948" @default.
• W4387362461 hasPublicationYear "2023" @default.
• W4387362461 type Work @default.
• W4387362461 citedByCount "0" @default.
• W4387362461 crossrefType "journal-article" @default.
• W4387362461 hasAuthorship W4387362461A5037510195 @default.
• W4387362461 hasAuthorship W4387362461A5074328280 @default.
• W4387362461 hasAuthorship W4387362461A5093007384 @default.
• W4387362461 hasBestOaLocation W43873624611 @default.
• W4387362461 hasConcept C126322002 @default.
• W4387362461 hasConcept C126838900 @default.
• W4387362461 hasConcept C127413603 @default.
• W4387362461 hasConcept C137627325 @default.
• W4387362461 hasConcept C164705383 @default.
• W4387362461 hasConcept C2776548475 @default.
• W4387362461 hasConcept C2776652619 @default.
• W4387362461 hasConcept C2779134260 @default.
• W4387362461 hasConcept C2780007028 @default.
• W4387362461 hasConcept C2780326628 @default.
• W4387362461 hasConcept C2780645631 @default.
• W4387362461 hasConcept C71924100 @default.
• W4387362461 hasConcept C78519656 @default.
• W4387362461 hasConceptScore W4387362461C126322002 @default.
• W4387362461 hasConceptScore W4387362461C126838900 @default.
• W4387362461 hasConceptScore W4387362461C127413603 @default.
• W4387362461 hasConceptScore W4387362461C137627325 @default.
• W4387362461 hasConceptScore W4387362461C164705383 @default.
• W4387362461 hasConceptScore W4387362461C2776548475 @default.
• W4387362461 hasConceptScore W4387362461C2776652619 @default.
• W4387362461 hasConceptScore W4387362461C2779134260 @default.
• W4387362461 hasConceptScore W4387362461C2780007028 @default.
• W4387362461 hasConceptScore W4387362461C2780326628 @default.
• W4387362461 hasConceptScore W4387362461C2780645631 @default.
• W4387362461 hasConceptScore W4387362461C71924100 @default.
• W4387362461 hasConceptScore W4387362461C78519656 @default.
• W4387362461 hasIssue "Supplement_1" @default.
• W4387362461 hasLocation W43873624611 @default.
• W4387362461 hasOpenAccess W4387362461 @default.
• W4387362461 hasPrimaryLocation W43873624611 @default.
• W4387362461 hasRelatedWork W1576015456 @default.
• W4387362461 hasRelatedWork W2021297856 @default.
• W4387362461 hasRelatedWork W2099986469 @default.
• W4387362461 hasRelatedWork W2150526189 @default.
• W4387362461 hasRelatedWork W2370965905 @default.
• W4387362461 hasRelatedWork W2392802952 @default.
• W4387362461 hasRelatedWork W2413149257 @default.
• W4387362461 hasRelatedWork W2980975149 @default.
• W4387362461 hasRelatedWork W3049646086 @default.
• W4387362461 hasRelatedWork W4377564970 @default.
• W4387362461 hasVolume "7" @default.
• W4387362461 isParatext "false" @default.
• W4387362461 isRetracted "false" @default.
• W4387362461 workType "article" @default.